While POLG1 expression was significantly upregulated in several cancers including salivary gland, myeloma, pancreas, melanoma, prostate and colorectal cancers (Fig 1A), its expression was significantly decreased in lung, head and neck, brain, bladder, cervix, leukemia and esophageal cancer (Fig 1B). Here, POLG is linked to cancer.